Streetbeat News

Stock Prices

RMR

RMR Gr (NASDAQ:RMR) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts expecting an EPS of $0.45. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing subsequent share price drops. Shares are currently trading at $24.85, reflecting a 9.91% decrease over the last year. Investors are likely focused on the company's guidance for future growth as a key factor influencing stock price.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 8:01 pm

COTY

Coty (NYSE:COTY) is expected to report an EPS of $0.20 in its upcoming quarterly earnings on 2024-02-07. Analysts and investors are keen on whether Coty will surpass this estimate and provide positive guidance for future growth. Historical data shows mixed reactions to past earnings reports, with the last quarter missing estimates but still resulting in a share price increase. Coty's shares have risen 20.77% over the last 52 weeks, indicating a positive outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 8:01 pm

CLSK

In the last three months, 5 analysts have updated their ratings on Cleanspark (NASDAQ:CLSK), showing a shift towards a more bullish outlook. The average 12-month price target has been raised to $11.2, up 12% from the previous $10.00, with ratings ranging from 'Buy' to 'Overweight'. Cleanspark, a bitcoin mining company, has shown significant revenue growth of 98.83% as of September 30, 2023, but struggles with a high net margin loss of -140.98% and below-average ROE and ROA, indicating potential profitability and efficiency challenges.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 8:00 pm

SPGI

Over the past 10 years, S&P Global (NYSE:SPGI) has produced an average annual return of 18.81%, outperforming the market. A $100 investment in SPGI a decade ago would be worth $567.89 today, showcasing the impact of compounded returns on investment growth. S&P Global currently has a market capitalization of $142.73 billion.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 8:00 pm

NANC

NVDA

Nancy Pelosi and her husband gained over $1 million from Nvidia (NVDA) call options, with the transaction occurring in November and the stake now worth over $3 million. Nvidia's strong performance and partnership with the U.S. government on AI research have contributed to its success. Pelosi's stock transactions, including a previous sale of Nvidia shares at a loss, have been scrutinized, especially in light of the CHIPS Act and her visit to Taiwan. The Unusual Whales Subversive Democratic Trading ETF (NANC) tracks stock trading activity of Democrats in Congress.

Portfolio Pulse from Chris Katje

February 06, 2024 | 8:00 pm

UBER

Analysts from Keybanc, JMP, and Mizuho have raised their price targets for Uber Technologies Inc (NYSE:UBER), citing expectations for enhanced earnings, strategic buybacks up to $5B, and strong growth prospects. Keybanc's analyst expects Q4 GBV of $37.1 billion and EBITDA of $1.24 billion, with a raised price target from $70 to $79. JMP's analyst anticipates healthy top-line results and broad profitability, raising the target from $62 to $75. Mizuho's analyst reiterates a Buy rating with a $77 price target, expecting strong EBITDA results from favorable unit economics and market share gains.

Portfolio Pulse from Anusuya Lahiri

February 06, 2024 | 7:59 pm

KSS

Kohl's shares are experiencing an uptick after reports emerged that a hedge fund, led by former Canadian Prime Minister Stephen Harper, is advocating for the company to sell itself.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:56 pm

VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced positive results from its vanzacaftor/tezacaftor/deutivacaftor (vanza triple) program for cystic fibrosis, showing non-inferiority to Trikafta in lung function improvement. Concurrently, Vertex released its Q4 2023 financial results. Goldman Sachs reiterated a Buy rating with a new price target of $578. The vanza triple therapy offers advantages over Trikafta, including once-daily dosing and lower royalty burdens, potentially attracting 6,000 patients who stopped using other Vertex CF medications. VRTX shares dropped 2.89% to $416.51.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 7:55 pm

DIS

Deep-pocketed investors have shown a bullish sentiment towards Walt Disney (NYSE:DIS) options, with a notable increase in activity. Benzinga's tracking revealed 49 extraordinary options activities, with a majority leaning bullish. The significant trading activity suggests a price target range of $75.0 to $125.0 for DIS over the next three months. The analysis of volume and open interest in DIS options provides insights into market liquidity and interest. Current trading volume and a slight price increase in DIS stock are also highlighted, alongside a mention of its next earnings report.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:46 pm

ARM

Deep-pocketed investors have shown a bullish trend in options trading for ARM Holdings (NASDAQ:ARM), with a significant move suggesting a big event on the horizon. Benzinga's options scanner revealed 25 extraordinary activities, with a bullish sentiment from 56% of investors. The trading activity predicts ARM's price to range between $60.0 and $82.0 in the next three months. Currently, ARM's stock is up by 2.35%, trading at $74.99, with an anticipated earnings release in 1 day. Keybanc maintains an Overweight rating with a target price of $75.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:45 pm